Literature DB >> 20114092

Taking a lesson from microbial diarrheagenesis in the management of chronic constipation.

Adil E Bharucha, Scott A Waldman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20114092      PMCID： PMC3141216          DOI： 10.1053/j.gastro.2010.01.022

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  24 in total

Review 1.  Guanylin regulatory peptides: structures, biological activities mediated by cyclic GMP and pathobiology.

Authors:  L R Forte
Journal:  Regul Pept       Date:  1999-05-31

Review 2.  Guanylyl cyclases and signaling by cyclic GMP.

Authors:  K A Lucas; G M Pitari; S Kazerounian; I Ruiz-Stewart; J Park; S Schulz; K P Chepenik; S A Waldman
Journal:  Pharmacol Rev       Date:  2000-09       Impact factor: 25.468

3.  Repression of heat-stable enterotoxin synthesis in enterotoxigenic Escherichia coli.

Authors:  J F Alderete; D C Robertson
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

4.  Regulation of intestinal uroguanylin/guanylin receptor-mediated responses by mucosal acidity.

Authors:  F K Hamra; S L Eber; D T Chin; M G Currie; L R Forte
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

5.  Capacity of the human colon to absorb fluid.

Authors:  J C Debongnie; S F Phillips
Journal:  Gastroenterology       Date:  1978-04       Impact factor: 22.682

Review 6.  Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics.

Authors:  Leonard Ralph Forte
Journal:  Pharmacol Ther       Date:  2004-11       Impact factor: 12.310

7.  The Escherichia coli heat-stable enterotoxin is a long-lived superagonist of guanylin.

Authors:  B W Carpick; J Gariépy
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

8.  Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia.

Authors:  Giuseppe Chiarioni; William E Whitehead; Vincenzo Pezza; Antonio Morelli; Gabrio Bassotti
Journal:  Gastroenterology       Date:  2006-03       Impact factor: 22.682

Review 9.  The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000.

Authors:  Margaret Kosek; Caryn Bern; Richard L Guerrant
Journal:  Bull World Health Organ       Date:  2003-05-16       Impact factor: 9.408

10.  Age-related differences in receptors for Escherichia coli heat-stable enterotoxin in the small and large intestine of children.

Authors:  M B Cohen; A Guarino; R Shukla; R A Giannella
Journal:  Gastroenterology       Date:  1988-02       Impact factor: 22.682
View more
  17 in total

Review 1.  Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases.

Authors:  Lincoln R Potter
Journal:  Pharmacol Ther       Date:  2010-12-24       Impact factor: 12.310

Review 2.  American Gastroenterological Association technical review on constipation.

Authors:  Adil E Bharucha; John H Pemberton; G Richard Locke
Journal:  Gastroenterology       Date:  2013-01       Impact factor: 22.682

Review 3.  Existing and emerging therapies for managing constipation and diarrhea.

Authors:  Adil E Bharucha; Mira M Wouters; Jan Tack
Journal:  Curr Opin Pharmacol       Date:  2017-11-21       Impact factor: 5.547

4.  Plecanatide, an oral guanylate cyclase C agonist acting locally in the gastrointestinal tract, is safe and well-tolerated in single doses.

Authors:  Kunwar Shailubhai; Stephen Comiskey; John A Foss; Rong Feng; Laura Barrow; Gail M Comer; Gary S Jacob
Journal:  Dig Dis Sci       Date:  2013-04-27       Impact factor: 3.199

Review 5.  Brain-gut axis: from basic understanding to treatment of IBS and related disorders.

Authors:  Michael Camilleri; Carlo Di Lorenzo
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-04       Impact factor: 2.839

6.  Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention.

Authors:  David S Weinberg; Jieru E Lin; Nathan R Foster; Gary Della'Zanna; Asad Umar; Drew Seisler; Walter K Kraft; David M Kastenberg; Leo C Katz; Paul J Limburg; Scott A Waldman
Journal:  Cancer Prev Res (Phila)       Date:  2017-04-10

Review 7.  Chronic Constipation.

Authors:  Adil E Bharucha; Arnold Wald
Journal:  Mayo Clin Proc       Date:  2019-05-01       Impact factor: 7.616

8.  Linaclotide: evidence for its potential use in irritable bowel syndrome and chronic constipation.

Authors:  Noel Lee; Arnold Wald
Journal:  Core Evid       Date:  2012-06-25

9.  Contrasting effects of linaclotide and lubiprostone on restitution of epithelial cell barrier properties and cellular homeostasis after exposure to cell stressors.

Authors:  John Cuppoletti; Anthony T Blikslager; Jayati Chakrabarti; Prashant K Nighot; Danuta H Malinowska
Journal:  BMC Pharmacol       Date:  2012-05-03

10.  Linaclotide.

Authors:  Dennis J Cada; Terri L Levien; Danial E Baker
Journal:  Hosp Pharm       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.